# NOVOCART 3D Treatment Following Microfracture Failure

> **NCT03219307** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Aesculap Biologics, LLC** · enrollment: 30 (estimated)

## Conditions studied

- Articular Cartilage Defect

## Interventions

- **COMBINATION_PRODUCT:** NOVOCART 3D

## Key facts

- **NCT ID:** NCT03219307
- **Lead sponsor:** Aesculap Biologics, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-11-30
- **Primary completion:** 2026-01
- **Final completion:** 2029-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03219307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03219307, "NOVOCART 3D Treatment Following Microfracture Failure". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03219307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*